ROPIVACAÏNE KABI 2 mg/ml, solution for infusion in a bag 5 bags of 100 ml
Active ingredients: Ropivacaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusion5 bags of 100 mlinfiltration;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROPIVACAÏNE KABI 2 mg/ml, solution pour perfusion en poche
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- infiltration;péridurale;périneurale
- Presentation description
- 5 poche(s) polyoléfine suremballée(s)/surpochée(s) de 100 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Feb 2011
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66851902CIP75774338CIP133400957743383Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPIVACAÏNEsolution | 2 mg · 1 ml de solution pour perfusion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.